vendredi 8 juin 2018

Onco Actu du 8 juin 2018

2. Etiologie

U.S lawmakers seek answers from new head of WHO's cancer agency [Reuters]

Does IARC's Proposed Revision Of Its Preamble Signal A Real Change In The Agency's Behavior? [Forbes]

3.1 Prévention - Tabac

Statement from FDA Commissioner Scott Gottlieb, M.D., on 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco products [FDA]

3.1.1 Prévention - Tabac - e-cigs

Exclusive: Philip Morris plans to target Indian smokers with iQOS device - sources [Reuters]

3.3 Prévention - Vaccins

Merck Acknowledges Efforts by WHO, ACS, and NCI-Designated Cancer Centers to Reduce the Number of Men and Women Affected by HPV-related Cancers [Merck]

American Association for Cancer Research Supports Goal of Eliminating HPV-related Cancers in the United States [AACR]

5. Traitements

Cure for a common turtle cancer takes a lesson from human cancers [Science]

Fatal interstitial lung disease caused by Panitumumab-containing chemotherapy regimen [ecancer]

5.10 Traitements - Essais

Novartis announces JCO publication of Lutathera® NETTER-1 data showing significantly longer time to deterioration of key quality of life measures in patients with progressive midgut NETs [Novartis]

5.12.2 Immunothérapies - CAR-T, thérapies cellulaires

FierceBiotech BIO breakfast—CAR-T 2.0: Biomedical science at the cutting edge [FierceBiotech]

New Insights to Improve CAR T Cells’ Safety [The Scientist]

5.12.5 Immunothérapies - Pharma

Ex-Takeda executive takes up CMO post at CD47 biotech Trillium [FierceBiotech]

Oncologie kicks off trans-Pacific operations with $16.5M in seed funding [FierceBiotech]

5.2 Pharma

PARP battle heats up as Pfizer nabs priority review for talazoparib in breast cancer [FiercePharma]

U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation [Pfizer]

Mega-blockbuster? Pfizer lines up for a snap review of its PARP drug talazoparib — and a launch into a crowded market [EndPoints]

5.2.3 Pharma - économie

The Gates Foundation rolls outs details of its new biotech, one without a profit motive [STAT]

Bill And Melinda Gates Start A Nonprofit Biotech In Boston [Forbes]

5.4 Traitements - Economie

AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024 [FiercePharma]

Prostate cancer drug given initial ‘no’ for NHS in England [Cancer Research UK] ASCO (immunothérapies-CAR-T, thérapies cellulaires)

One cancer patient’s dramatic response to immunotherapy. But … [HealthNewsReview]

5.5.8 ASCO (poumon)

How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab [Forbes]

6.1 Observation

Older breast cancer patients in England less likely to survive than in four other European countries [Cancer Research UK]

6.11 Patients

I'm an oncologist who got breast cancer. This is what I learned [The Guardian]

6.6 Publications

Mapping the PID Landscape [ORCID]

6.7.1 IA/bioinformatique

Artificial intelligence will improve medical treatments [The Economist]